Enriching protein-protein and functional interaction networks in human embryonic stem cells

International Journal of Molecular Medicine

Volumn 23, Issue 6, 2009, Pages 811-819

  Zuo, Changqing ^a   Liang, Shuang ^a   Wang, Zonggui ^b   Li, Hua ^a   Zheng, Wenling ^c   Ma, Wenli ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c Southern China Genomics Research Center   (China)

Author keywords

Bioinformatics; Embryonic stem cell; Gene ontology; Protein interaction; Scare free network

Indexed keywords

CYCLIN DEPENDENT KINASE 1; MYC PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DDX18; TRANSCRIPTION FACTOR H2AFX; TRANSCRIPTION FACTOR HDAC2; TRANSCRIPTION FACTOR HIST1H4C; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR RUVBL1; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION REHULATION NY F; UNCLASSIFIED DRUG;

ALGORITHM; AMINO ACID SEQUENCE; ARTICLE; CELL SPECIFICITY; COMPUTER MODEL; COMPUTER PROGRAM; EMBRYONIC STEM CELL; GENE FUNCTION; HUMAN; I2D DATABASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN PROTEIN INTERACTION; TISSUE SPECIFICITY;

COMPUTATIONAL BIOLOGY; EMBRYONIC STEM CELLS; HUMANS; PROTEIN BINDING; PROTEINS;

EID: 67649522013     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000197     Document Type: Article

References (64)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al: Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.
2. Newman MB and Bakay RA: Therapeutic potentials of human embryonic stem cells in Parkinson's disease. Neurotherapeutics 5: 237-251, 2008.
3. Docherty K, Bernardo AS and Vallier L: Embryonic stem cell therapy for diabetes mellitus. Semin Cell Dev Biol 18: 827-838, 2007.
4. Siu CW, Moore JC and Li RA: Human embryonic stem cell-derived cardiomyocytes for heart therapies. Cardiovasc Hematol Disord Drug Targets 7: 145-152, 2007.
5. Kang HK, Roh S, Lee G, Hong SD, Kang H and Min BM: Osteogenic potential of embryonic stem cells in tooth sockets. Int J Mol Med 21: 539-544, 2008.
6. Nichols J, Zevnik B, Anastassiadis K, et al: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391, 1998.
7. Chambers I, Colby D, Robertson M, et al: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655, 2003.
8. Rogers MB, Hosler BA and Gudas LJ: Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 113: 815-824, 1991.
9. Graham V, Khudyakov J, Ellis P and Pevny L: SOX2 functions to maintain neural progenitor identity. Neuron 39: 749-765, 2003.
10. Hanna LA, Foreman RK, Tarasenko IA, Kessler DS and Labosky PA: Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev 16: 2650-2661, 2002.
11. Wuchty S, Barabasi AL and Ferdig MT: Stable evolutionary signal in a yeast protein interaction network. BMC Evol Biol 6: 8, 2006.
12. Brown KR and Jurisica I: Unequal evolutionary conservation of human protein interactions in interologous networks. Genome Biol 8: R95, 2007.
13. Kim J, Chu J, Shen X, Wang J and Orkin SH: An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049-1061, 2008.
14. Jiang J, Chan YS, Loh YH, et al: A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10: 353-360, 2008.
15. Loh YH, Wu Q, Chew JL, et al: The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440, 2006.
16. Zhou Q, Chipperfield H, Melton DA and Wong WH: A gene regulatory network in mouse embryonic stem cells. Proc Natl Acad Sci USA 104: 16438-16443, 2007.
17. Chuang HY, Lee E, Liu YT, Lee D and Ideker T: Network-based classification of breast cancer metastasis. Mol Syst Biol 3: 140, 2007.
18. Hahn MW and Kern AD: Comparative genomics of centrality and essentiality in three eukaryotic protein-interaction networks. Mol Biol Evol 22: 803-806, 2005.
19. Ideker T and Sharan R: Protein networks in disease. Genome Res 18: 644-652, 2008.
20. Wang J, Rao S, Chu J, et al: A protein interaction network for pluripotency of embryonic stem cells. Nature 444: 364-368, 2006.
21. Assou S, Le Carrour T, Tondeur S, et al: A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25: 961-973, 2007.
22. Brown KR and Jurisica I: Online predicted human interaction database. Bioinformatics 21: 2076-2082, 2005.
23. Yu X, Lin J, Zack DJ and Qian J: Computational analysis of tissue-specific combinatorial gene regulation: predicting interaction between transcription factors in human tissues. Nucleic Acids Res 34: 4925-4936, 2006.
24. Liang S, Li Y, Be X, Howes S and Liu W: Detecting and profiling tissue-selective genes. Physiol Genomics 26: 158-162, 2006.
25. Shannon P, Markiel A, Ozier O, et al: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504, 2003.
26. Hosack DA, Dennis G Jr, Sherman BT, Lane HC and Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70, 2003.
27. Barabasi AL and Oltvai ZN: Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113, 2004.
28. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
29. Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006.
30. Boyer LA, Lee TI, Cole MF, et al: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956, 2005.
31. Fernandez PC, Frank SR, Wang L, et al: Genomic targets of the human c-Myc protein. Genes Dev 17: 1115-1129, 2003.
32. Feng Y, Lee N and Fearon ER: TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Cancer Res 63: 8726-8734, 2003.
33. Prochownik EV: c-Myc: linking transformation and genomic instability. Curr Mol Med 8: 446-458, 2008.
34. Ji P, Diederichs S, Wang W, et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041, 2003.
35. Dubaele S and Chene P: Cellular studies of MrDb (DDX18). Oncol Res 16: 549-556, 2007.
36. Bassing CH, Suh H, Ferguson DO, et al: Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114: 359-370, 2003.
37. Malkas LH, Herbert BS, Abdel-Aziz W, et al: A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci USA 103: 19472-19477, 2006.
38. Powers MV, Clarke PA and Workman P: Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell 14: 250-262, 2008.
39. Montanaro L, Brigotti M, Clohessy J, et al: Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol 210: 10-18, 2006.
40. Chen H, Huang Q, Dong J, Zhai DZ, Wang AD and Lan Q: Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo. BMC Cancer 8: 29, 2008.
41. Graff JR, Konicek BW, Carter JH and Marcusson EG: Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 68: 631-634, 2008.
42. Killian A, Sarafan-Vasseur N, Sesboue R, et al: Contribution of the BOP1 gene, located on 8q24, to colorectal tumorigenesis. Genes Chromosomes Cancer 45: 874-881, 2006.
43. Chang TW, Chen CC, Chen KY, Su JH, Chang JH and Chang MC: Ribosomal phosphoprotein P0 interacts with GCIP and over-expression of P0 is associated with cellular proliferation in breast and liver carcinoma cells. Oncogene 27: 332-338, 2008.
44. Zhang L, Pan X and Hershey JW: Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 282: 5790-5800, 2007.
45. Weichert W, Roske A, Gekeler V, et al: Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer 98: 604-610, 2008.
46. Jeong H, Mason SP, Barabasi AL and Oltvai ZN: Lethality and centrality in protein networks. Nature 411: 41-42, 2001.
47. Said MR, Begley TJ, Oppenheim AV, Lauffenburger DA and Samson LD: Global network analysis of phenotypic effects: protein networks and toxicity modulation in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 101: 18006-18011, 2004.
48. Shachar R, Ungar L, Kupiec M, Ruppin E and Sharan R: A systems-level approach to mapping the telomere length maintenance gene circuitry. Mol Syst Biol 4: 172, 2008.
49. Albert R: Scale-free networks in cell biology. J Cell Sci 118: 4947-4957, 2005.
50. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K and Dalton S: LIF/ STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896, 2005.
51. Andang M, Hjerling-Leffler J, Moliner A, et al: Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. Nature 451: 460-464, 2008.
52. Sun Y, Li H, Liu Y, Mattson MP, Rao MS and Zhan M: Evolutionarily conserved transcriptional co-expression guiding embryonic stem cell differentiation. PLoS ONE 3: E3406, 2008.
53. Wood MA, McMahon SB and Cole MD: An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 5: 321-330, 2000.
54. Qiu XB, Lin YL, Thome KC, et al: An eukaryotic RuvB-like protein (RUVBL1) essential for growth. J Biol Chem 273: 27786-27793, 1998.
55. Armstrong L, Hughes O, Yung S, et al: The role of PI3K/AKT, MAPK/ ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15: 1894-1913, 2006.
56. Murakami M, Ichisaka T, Maeda M, et al: mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24: 6710-6718, 2004.
57. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C and Kahn M: Wnt/ beta-catenin/CBP signaling maintains longterm murine embryonic stem cell pluripotency. Proc Natl Acad Sci USA 104: 5668-5673, 2007.
58. Grskovic M, Chaivorapol C, Gaspar-Maia A, Li H and Ramalho-Santos M: Systematic identification of cis-regulatory sequences active in mouse and human embryonic stem cells. PLoS Genet 3: E145, 2007.
59. Zhu J, Zhang Y, Joe GJ, Pompetti R and Emerson SG: NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal. Proc Natl Acad Sci USA 102: 11728-11733, 2005.
60. Hentze H, Graichen R and Colman A: Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol 25: 24-32, 2007.
61. Vogel G: Cell biology. Ready or not? Human ES cells head toward the clinic. Science 308: 1534-1538, 2005.
62. Lobo NA, Shimono Y, Qian D and Clarke MF: The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699, 2007.
63. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
64. Ben-Porath I, Thomson MW, Carey VJ, et al: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507, 2008.